Tokyo, Japan

Kenji Ohishi

This inventor holds 3 USPTO granted patents. Top assignee: Kabushiki Kaisha Yakult Honsha. Active years: 2006-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Ohishi. Retrieved from https://idiyas.com/inventor/kenji-ohishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kenji Ohishi: Innovator in Cholesterol-Lowering Agents

Introduction

Kenji Ohishi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of health and nutrition through his innovative research and development of cholesterol-lowering agents. With a total of 3 patents to his name, Ohishi continues to impact the industry with his groundbreaking work.

Latest Patents

Ohishi's latest patents focus on cholesterol-lowering agents and secondary bile acid production inhibitors. His inventions include foods and drinks that contain secondary bile acid production inhibitors and cholesterol-lowering agents, utilizing yeast as the active ingredient. These patents reflect his commitment to improving health outcomes through innovative dietary solutions.

Career Highlights

Kenji Ohishi is associated with Kabushiki Kaisha Yakult Honsha, a company known for its dedication to health and wellness products. His work at Yakult has allowed him to explore various avenues in nutritional science, leading to the development of effective health solutions.

Collaborations

Ohishi has collaborated with notable colleagues such as Haruji Sawada and Yasuto Yoshida. Their combined expertise has contributed to the advancement of research in the field of cholesterol management and health improvement.

Conclusion

Kenji Ohishi stands out as an influential inventor in the realm of health innovations. His dedication to developing effective cholesterol-lowering agents showcases his commitment to enhancing public health through scientific research and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…